The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors

Christopher J. Sweeney, Kathy D. Miller, Sean E. Sissons, Shinichi Nozaki, Douglas K. Heilman, Jianzhao Shen, George W. Sledge

Research output: Contribution to journalArticle

305 Scopus citations

Fingerprint Dive into the research topics of 'The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors'. Together they form a unique fingerprint.

Medicine & Life Sciences